365 related articles for article (PubMed ID: 12032324)
1. UL40-mediated NK evasion during productive infection with human cytomegalovirus.
Wang EC; McSharry B; Retiere C; Tomasec P; Williams S; Borysiewicz LK; Braud VM; Wilkinson GW
Proc Natl Acad Sci U S A; 2002 May; 99(11):7570-5. PubMed ID: 12032324
[TBL] [Abstract][Full Text] [Related]
2. The natural killer cell-mediated killing of autologous dendritic cells is confined to a cell subset expressing CD94/NKG2A, but lacking inhibitory killer Ig-like receptors.
Della Chiesa M; Vitale M; Carlomagno S; Ferlazzo G; Moretta L; Moretta A
Eur J Immunol; 2003 Jun; 33(6):1657-66. PubMed ID: 12778484
[TBL] [Abstract][Full Text] [Related]
3. Natural killer cell receptors for major histocompatibility complex class I and related molecules in cytomegalovirus infection.
López-Botet M; Angulo A; Gumá M
Tissue Antigens; 2004 Mar; 63(3):195-203. PubMed ID: 14989708
[TBL] [Abstract][Full Text] [Related]
4. Synergistic effect of IFN-gamma and human cytomegalovirus protein UL40 in the HLA-E-dependent protection from NK cell-mediated cytotoxicity.
Cerboni C; Mousavi-Jazi M; Wakiguchi H; Carbone E; Kärre K; Söderström K
Eur J Immunol; 2001 Oct; 31(10):2926-35. PubMed ID: 11592068
[TBL] [Abstract][Full Text] [Related]
5. Influence of human cytomegalovirus infection on the NK cell receptor repertoire in children.
Monsiváis-Urenda A; Noyola-Cherpitel D; Hernández-Salinas A; García-Sepúlveda C; Romo N; Baranda L; López-Botet M; González-Amaro R
Eur J Immunol; 2010 May; 40(5):1418-27. PubMed ID: 20201038
[TBL] [Abstract][Full Text] [Related]
6. HCMV infection of PDCs deviates the NK cell response into cytokine-producing cells unable to perform cytotoxicity.
Cederarv M; Söderberg-Nauclér C; Odeberg J
Immunobiology; 2009; 214(5):331-41. PubMed ID: 19152985
[TBL] [Abstract][Full Text] [Related]
7. Human leukocyte antigen E in human cytomegalovirus infection: friend or foe?
Gong F; Song S; Lv G; Pan Y; Zhang D; Jiang H
Acta Biochim Biophys Sin (Shanghai); 2012 Jul; 44(7):551-4. PubMed ID: 22576308
[TBL] [Abstract][Full Text] [Related]
8. Expansion of CD94/NKG2C+ NK cells in response to human cytomegalovirus-infected fibroblasts.
Gumá M; Budt M; Sáez A; Brckalo T; Hengel H; Angulo A; López-Botet M
Blood; 2006 May; 107(9):3624-31. PubMed ID: 16384928
[TBL] [Abstract][Full Text] [Related]
9. Natural killer cell lysis of cytomegalovirus (CMV)-infected cells correlates with virally induced changes in cell surface lymphocyte function-associated antigen-3 (LFA-3) expression and not with the CMV-induced down-regulation of cell surface class I HLA.
Fletcher JM; Prentice HG; Grundy JE
J Immunol; 1998 Sep; 161(5):2365-74. PubMed ID: 9725232
[TBL] [Abstract][Full Text] [Related]
10. The inhibitory NK cell receptor CD94/NKG2A and the activating receptor CD94/NKG2C bind the top of HLA-E through mostly shared but partly distinct sets of HLA-E residues.
Wada H; Matsumoto N; Maenaka K; Suzuki K; Yamamoto K
Eur J Immunol; 2004 Jan; 34(1):81-90. PubMed ID: 14971033
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of natural killer cells by a cytomegalovirus MHC class I homologue in vivo.
Farrell HE; Vally H; Lynch DM; Fleming P; Shellam GR; Scalzo AA; Davis-Poynter NJ
Nature; 1997 Apr; 386(6624):510-4. PubMed ID: 9087412
[TBL] [Abstract][Full Text] [Related]
12. Spontaneous mutations in the human CMV HLA class I homologue UL18 affect its binding to the inhibitory receptor LIR-1/ILT2/CD85j.
Cerboni C; Achour A; Wärnmark A; Mousavi-Jazi M; Sandalova T; Hsu ML; Cosman D; Kärre K; Carbone E
Eur J Immunol; 2006 Mar; 36(3):732-41. PubMed ID: 16479538
[TBL] [Abstract][Full Text] [Related]
13. The effect of mifepristone on the peripheral blood natural killer cell's cytotoxicity and expression of CD94/NKG2A and NKG2D during the implantation phase.
Chen XY; Zhuang YL; Li L; Zhang WW; Huang LL
Fertil Steril; 2010 May; 93(8):2615-20. PubMed ID: 19880106
[TBL] [Abstract][Full Text] [Related]
14. Expression patterns of lectin-like natural killer receptors, inhibitory CD94/NKG2A, and activating CD94/NKG2C on decidual CD56bright natural killer cells differ from those on peripheral CD56dim natural killer cells.
Kusumi M; Yamashita T; Fujii T; Nagamatsu T; Kozuma S; Taketani Y
J Reprod Immunol; 2006 Jun; 70(1-2):33-42. PubMed ID: 16488482
[TBL] [Abstract][Full Text] [Related]
15. Selective intracellular retention of virally induced NKG2D ligands by the human cytomegalovirus UL16 glycoprotein.
Welte SA; Sinzger C; Lutz SZ; Singh-Jasuja H; Sampaio KL; Eknigk U; Rammensee HG; Steinle A
Eur J Immunol; 2003 Jan; 33(1):194-203. PubMed ID: 12594848
[TBL] [Abstract][Full Text] [Related]
16. The class I MHC homologue of human cytomegalovirus inhibits attack by natural killer cells.
Reyburn HT; Mandelboim O; Valés-Gómez M; Davis DM; Pazmany L; Strominger JL
Nature; 1997 Apr; 386(6624):514-7. PubMed ID: 9087413
[TBL] [Abstract][Full Text] [Related]
17. Polymorphism in human cytomegalovirus UL40 impacts on recognition of human leukocyte antigen-E (HLA-E) by natural killer cells.
Heatley SL; Pietra G; Lin J; Widjaja JML; Harpur CM; Lester S; Rossjohn J; Szer J; Schwarer A; Bradstock K; Bardy PG; Mingari MC; Moretta L; Sullivan LC; Brooks AG
J Biol Chem; 2013 Mar; 288(12):8679-8690. PubMed ID: 23335510
[TBL] [Abstract][Full Text] [Related]
18. Differential effects of US2, US6 and US11 human cytomegalovirus proteins on HLA class Ia and HLA-E expression: impact on target susceptibility to NK cell subsets.
Llano M; Gumá M; Ortega M; Angulo A; López-Botet M
Eur J Immunol; 2003 Oct; 33(10):2744-54. PubMed ID: 14515258
[TBL] [Abstract][Full Text] [Related]
19. Transgenic expression of HLA-E single chain trimer protects porcine endothelial cells against human natural killer cell-mediated cytotoxicity.
Lilienfeld BG; Crew MD; Forte P; Baumann BC; Seebach JD
Xenotransplantation; 2007 Mar; 14(2):126-34. PubMed ID: 17381687
[TBL] [Abstract][Full Text] [Related]
20. Antiviral activity against CMV-infected fibroblasts in pediatric patients transplanted with CD34(+)-selected allografts from alternative donors.
Lang P; Griesinger A; Hamprecht K; Feuchtinger T; Schumm M; Neuhäuser F; Greil J; Martin D; Handgretinger R; Niethammer D
Hum Immunol; 2004 May; 65(5):423-31. PubMed ID: 15172441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]